|
| |
| Oncology Diagnostics - Asuragen |
|
|
| Asuragen offer a range of kits for the diagnosis of specific cancers using their unique Signature? technology, which has been optimised for the rapid multiplex analysis of nucleic acid sequences. Up to 100 DNA or RNA targets can be detected in a single reaction. With medium density capability and a streamlined workflow, the Signature products allow for rapid detection of multiple analytes in a single assay, increase the number of assays available on a single platform, and reduce the overall turn around time. The Signature? technology has been optimised for the rapid detection of LTx v2.0 CE IVD Kit (Leukaemia Translocation Panel), KRAS/BRAF detection for colorectal cancers and Acute Myeloid Leukaemia (AML) as qualitative in vitro diagnostic devices for use in a clinical laboratory to aid in the clinical diagnosis of cancers. |
|
